Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes

Journal of Neurochemistry

Volumn 87, Issue 4, 2003, Pages 851-860

  Puttaparthi, Krishna ^a   Wojcik, Cezary ^a   Rajendran, Bhagya ^a   DeMartino, George N ^a   Elliott, Jeffrey L ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Aggregation; Aging; Amyotrophic lateral sclerosis; Motor neuron; Proteasome; Superoxide dismutase

Indexed keywords

PROTEASOME; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SPINAL CORD; TRANSGENIC MOUSE; WILD TYPE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CYSTEINE ENDOPEPTIDASES; ENZYME ACTIVATION; ENZYME INHIBITORS; MACROMOLECULAR SUBSTANCES; MICE; MICE, NEUROLOGIC MUTANTS; MICE, TRANSGENIC; MULTIENZYME COMPLEXES; ORGAN SPECIFICITY; PROTEASOME ENDOPEPTIDASE COMPLEX; SPINAL CORD; SUPEROXIDE DISMUTASE;

ANIMALIA; MUS MUSCULUS;

EID: 0344393089     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02028.x     Document Type: Article

References (29)

1. Bence N. F., Sampat R. M. and Kopito R. R. (2001) Impairment of the ubiquitin proteasome system by protein aggregation. Science 292, 1552-1555.
2. Bruijn L. I., Becher M. W., Lee M. K. et al. (1997) ALS-linked Sod1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327-338,
3. Cleveland D. W. (1999) From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. Neuron 24, 515-520.
4. Cleveland D. W. and Liu J. (2000) Oxidation versus aggregation - how do SOD1 mutants cause ALS. Nat. Med. 12, 1320-1321.
5. DeMartino G. N. and Slaughter C. A. (1999) The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274, 22 123-22 126.
6. Ding Q. and Keller J. N. (2001) Proteasomes and proteasome inhibition in the central nervous system. Free Rad. Biol. Med. 31, 574-584.
7. Elliott J. L. (1999) Experimental models of amyotrophic lateral sclerosis. Neurobiol. Dis. 6, 310-320.
8. Gong Y. H., Parsadanian A. S., Andreeva A., Snider W. D. and Elliott J. L. (2000) Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 20, 660-665.
9. Gurney M. E., Pu H., Chiu A. Y. et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn dismutase mutation. Science 264, 1772-1775.
10. Johnston J. A., Dalton M. J., Gurney M. E. and Kopito R. R. (2000) Formation of high molecular weight complexes of mutant Cu,Zn superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 97, 12 571-12 576.
11. Keller J. N., Huang F. F. and Markesberry W. R. (2000) Decreased levels of proteasome activity and proteasome expression in the aging spinal cord. Neuroscience 98, 149-156.
12. Lino M. M., Schneider C. and Caroni P. (2002) Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 22, 4825-4832.
13. Manning-Bog A. B., McCormack J. L., Uversky V. N., Fink A. L. and DiMonte D. A. (2002) The herbicide paraquat causes upregulation and aggregation of α-synuclein in mice. J. Biol. Chem. 277, 1641-1644.
14. Martin-Aparicio E. M., Yamomoto A., Hernandez F., Hen R., Avila J. and Lucas J. J. (2001) Proteasomal dependant aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease. J. Neurosci. 21, 8772-8781.
15. McCutchen-Maloney S/L., Matsuda K., Shimbara N., Binns D. D., Tanaka K., Slaughter C. A. and DeMartino G. N. (2000) cDNA cloning expression and functional characterization of PI31, a proline rich inhibitor of the proteasome. J. Biol. Chem. 275, 18 557-18 565.
16. MingDai R. and Li C. C. H. (2001) Valosin containing protein is a multi-ubiquitin chain targeting factor required in ubiquitin proteasome degradation. Nat. Cell. Biol. 3, 740-744.
17. Pramatarova A., Laganiere L., Roussel J., Brisebois K. and Rouleau G. A. (2001) Neuron specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 21, 3369-3374.
18. Puttaparthi K., Gitomer W. L., Krishnan U., Son M., Rajendran B. and Elliott J. L. (2002) Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependant on both neuronal and non-neuronal zinc binding proteins. J. Neurosci. 22, 8790-8796.
19. Reaume A. G., Elliott J. L., Hoffman E. K. et al. (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13, 43-47.
20. Ripps M. E., Huntley G. W., Hof P. R., Morrison J. H. and Gordon J. W. (1995) Transgenic mice expressing and altered superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 92, 689-693.
21. Rosen D. R., Siddique T., Patterson D. et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic sclerosis. Nature 362, 59-62.
22. Rothstein J. D., Jin L., Dykes-Hoberg M. and Kuncl R. W. (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl Acad. Sci. USA 90, 6591-6595.
23. Shibata N., Hirano A., Kobayashi M., Siddique T., Deng H. X., Hung W. Y., Kato T. and Asayama K. (1996) Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic sclerosis with posterior column involvement. J. Neuropathol. Exp. Neurol. 55, 481-490.
24. Son X., Von Kampen J., Slaughter C. A. and DeMartino G. N. (1997) Relative functions of the α and β subunits of the proteasome activator, PA28. J. Biol. Chem. 272, 27 994-28 000.
25. Urushitani M., Kurisu J., Tsukita K. and Takahashi R. (2002) Proteasomal inhibition by misfolded superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic slcerosis. J. Neurochem. 83, 1030-1042.
26. Wang J., Xu G. and Borchelt D. R. (2002) High molecular weight complexes of mutant superoxide dismutase1: age dependant and tissue specific accumulation. Neurobiol. Dis. 9, 139-148.
27. Watanabe M., Dykes-Hoberg M., Culotta V. C., Price D. L., Wong P. C. and Rothstein J. D. (2001) Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissue. Neurobiol. Dis. 8, 933-941.
28. Wong P. C., Pardo C. A., Borchelt D. R., Lee M. K., Copeland N. G., Jenkins N. A., Sisodia S. S., Cleveland D. W. and Price D. L. (1995) An adverse property of a familial ALS-linked SOD mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105-1116.
29. Yamamoto A., Lucas J. J. and Hen R. (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57-66.